Danaher Jobs

Be part of something altogether life-changing!

Working at Cytiva means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.

At Cytiva you will be able to continuously improve yourself and us – working on challenges that truly matter with people that care for each other, our customers, and their patients. With associates across 40+ countries, Cytiva is a place where every day is a learning opportunity – so you can grow your career and expand your skills in the long term.

Forming part of the Biotechnology segment at Danaher, we bring together dedicated technical expertise and talent to develop the next generation of life-changing therapeutics.

The European Patent Attorney for Cytiva is intimately involved in building and implementing the Intellectual Property (IP) strategy for protecting some of our core product portfolios relating to chromatography resins and protein ligands for Bioprocess, Cell therapy and Genomic Medicine applications. This will cover all aspects from collaborating closely with R&D and business colleagues in building world class IP protection, to execution of global IP litigations.

This position is part of our expert IP team consisting of twenty-six employees across the world and will report into the IP Leader, Bioprocess. It is a hybrid-role based out of Uppsala, Sweden. Do you have a passion for innovation and intellectual property? Then we would love to hear from you!

What you’ll do

• Work closely with R&D and product development teams to capture and protect commercially significant inventions.

• Draft and file high quality patent applications.

• Efficiently advance prosecution of pending patent applications, and manage global patent portfolio to ensure that meaningful protection is obtained.

• Develop IP strategies using various types of IP to create and nurture valuable IP assets.

• Perform freedom to operate reviews and minimize exposure to third party IP.

• Support IP aspects of business development, licensing, and Merger & Acquisition activities.

• Represent Cytiva in EPO opposition proceedings.

• Drive IP enforcement actions.

• Provide IP training to R&D, product and marketing teams.

Who you are

• Qualified European Patent Attorney or partly qualified with strong technical background.

• Technical background in biology, biochemistry, chemistry or related life sciences field.

• Excellent written and oral communication skills.

• Experience of devising innovative IP strategies.

• Good commercial awareness.

• Experience working in the life sciences or healthcare sector.

• Knowledge of laws, regulations, practices and procedures relating to patent procurement in Europe, US and Asia.

It would be a plus if you also possess previous experience in:

• Whilst expertise to advise on IP matters in the biology/chemistry fields is essential, experience and desire to work additionally in product areas pertaining to other technical fields would be desirable.

  Interview and selection will happen continuously and an opening can be filled before last day of application 2 May, 2024. If you have questions regarding the role, please reach out to Lennart Sörby lennart.sorby@cytiva.com

  Welcome in with you application!

  #LI-AH1

At Danaher we bring together science, technology and operational capabilities to accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.

At Danaher, we value diversity and the existence of similarities and differences, both visible and not, found in our workforce, workplace and throughout the markets we serve. Our associates, customers and shareholders contribute unique and different perspectives as a result of these diverse attributes.